Healthy Choice Wellness Corp. enters the back half of May with a fresh earnings miss on the books and shorts quietly retreating — a combination that leaves the stock's near-term narrative more about fundamental credibility than positioning pressure.
The most striking data point this week is the collapse in short interest. SI % FF has fallen 77% over the past month, dropping to roughly 1.1% of the free float by mid-May after peaking near 4% in early April. The week-on-week decline alone was 30%. At $6.1 million market cap and a $0.27 close, this is a micro-cap with a very shallow float — short positions here are small in absolute terms, but the speed of exit is notable. Shorts have been unwinding steadily since April 23, when shares outstanding on loan briefly touched their highest reading of the recent window.
The borrow market is sending a relaxed signal. Availability is comfortable at around 243% of short interest — meaning there are more than twice as many shares available to borrow as are currently borrowed — which confirms there is no squeeze dynamic at work. Cost to borrow has been remarkably stable, holding in a tight band around 10.6-10.7% APR for over six weeks without any meaningful move in either direction. Borrow conditions have not tightened despite the sharp reduction in short positions; shorts appear to have left voluntarily rather than been forced out.
The reason for that exit may be hiding in plain sight. On May 15, HCWC reported Q1 results that missed on both lines: EPS came in at -$0.17 against a -$0.06 consensus estimate, and revenue of $18.2 million fell well short of the $22.3 million expected. The stock has already priced in some pain — down nearly 7% on the week and trading at a $6.1 million market cap — but the revenue shortfall of nearly 18% is a material gap for a company of this size. Prior earnings events show a mixed reaction pattern: the March 2026 print produced a modest +4% next-day move, but the event before that drew a -10% single-day drop. The stock has not established a consistent post-earnings direction.
Ownership is tightly concentrated at the top. The three largest holders — Jeffrey Holman (CEO, 8.4%), Christopher Santi (President, 4.5%), and John Ollet (CFO, 2.9%) — collectively control roughly 15% of shares outstanding. The most recent insider trades on record are from September 2024, when all three bought shares at $10.00 — well above the current $0.27 price. Those trades are now stale at 18 months old and are not a current signal, but the gap between the purchase price and today's level illustrates how far the stock has travelled since its listing.
With no analyst coverage to anchor a price target and no upcoming earnings event flagged, the key watch item is whether the Q1 revenue miss represents a one-quarter stumble or a deteriorating revenue run-rate — that distinction will drive whether the short interest decline reflects newfound comfort or simply a lack of conviction on either side.
See the live data behind this article on ORTEX.
Open HCWC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
